Western Europe

Western Europe continues to be one of the largest pharmaceutical markets in the world. With greatly developed healthcare and medical systems, highly trained Investigators and standardization across multiple countries in the form of the European Clinical Trials Directive, Western Europe remains an important region for clinical research.

With our global headquarters in the UK, Orphan Reach is highly experienced in conducting studies across Western Europe.

  • United Kingdom
  • Germany
  • France
  • Spain
  • Italy
  • Belgium
  • The Netherlands
  • Luxembourg
  • Switzerland
  • Ireland
  • Austria
  • Portugal
  • Denmark
  • Sweden
  • Finland

    • To successfully deliver a European project, it requires a CRO that understands first-hand the different socio-economic environments across multiple countries with a strong foundations in Europe: Orphan Reach is such a CRO.



    Central and Eastern Europe

    Biopharmaceutical sponsors continue to realise the importance of including Central and Eastern Europe as an emerging region in their study country mix. This is supported by:

  • Availability of large homogeneous patient populations (predominantly treatment naïve).
  • Highly competitive Regulatory Authority and Ethics Committee timelines.
  • Large network of extremely well qualified investigators.
  • Quality and GCP compliance ensuring data obtained is to Western standards
  • Considerable cost savings in monitoring and investigator fees versus Western European countries

    • Orphan Reach is an expert in conducting clinical trials across the whole of Central and Eastern Europe. We have a solid team in place covering the region with highly experienced site teams (in many cases medically qualified, MDs) on the ground in each country. We have experience and provide coverage in the following countries:


  • Czech Republic
  • Hungary
  • Croatia
  • Serbia
  • Macedonia
  • Bulgaria
  • Poland
  • Slovakia
  • Slovenia
  • Bosnia
  • Montenegro
  • Romania

    • Central and Eastern Europe can be a smart choice and will deliver fast approval, rapid recruitment, high quality data and lower costs.